Capitalize on ready-to-use CRISPR kits & enzymes and drug discovery demand with competitive insights, untapped market analysis, and go-to-market strategies.Dublin, Oct. (GLOBE NEWSWIRE) -- "CRISPR ...

There were supplements galore, of course: algae tablets for detoxification, ketones for concentration, nitric oxide for ...

A peer-reviewed study of 230 human clinical samples found that a CRISPR-assisted nanodroplet assay identified NTM species and ...

Scientists edited the promoter of the rice gene OsGTL1 to lower stomatal density, raising instantaneous water use efficiency ...

“Disgust is the mechanism with which we can detect things which carry disease,” says Cole, a researcher at the University of ...

An AI model spotted a strange pattern in a virus's DNA that looks a little like CRISPR. Its makers cannot yet say what it ...

CRISPR Therapeutics and Vertex Pharmaceuticals have noted that the medicine currently has an addressable market of roughly 60 ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.39, moving -1.2% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.52%.

Human cells hold about two meters (6.6 feet) of DNA, folded and compacted to fit inside a nucleus. That packing is essential ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

Spread the loveImagine looking in the mirror and seeing a younger version of yourself, not just cosmetically, but at a ...

Spread the loveImagine turning back the clock, not on your watch, but on your very own cells. It sounds like something ...